Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.6422
-0.0392-5.75%
Post-market: 0.66490.0227+3.53%19:59 EDT
Volume:9.37M
Turnover:6.14M
Market Cap:178.53M
PE:-1.29
High:0.7000
Open:0.6741
Low:0.6345
Close:0.6814
52wk High:2.55
52wk Low:0.5261
Shares:278.00M
Float Shares:245.00M
Volume Ratio:0.56
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:5.71
PE(LYR):-2.49

Loading ...

Humacyte director Michael T. Constantino acquires common shares worth $9,840

Reuters
·
May 21

Humacyte Announces Symvess® Is NOW Under Contract With the Strategic Acquisition Center (Sac) of the U.S. Department of Veterans Affairs

THOMSON REUTERS
·
May 20

Press Release: Humacyte Announces Symvess(R) is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

Dow Jones
·
May 20

Humacyte (HUMA) Valuation Check As Q1 2026 Losses Meet Cost Cuts New Leadership And Global Agreements

Simply Wall St.
·
May 16

Humacyte Is Maintained at Buy by BTIG

Dow Jones
·
May 14

Humacyte Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Humacyte Q1 EPS $(0.09) Beats $(0.11) Estimate, Sales $495.000K Miss $1.455M Estimate

Benzinga Earnings
·
May 13

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 13

Humacyte appoints Todd Rasmussen chief surgical officer

Reuters
·
May 12

Humacyte Appoints DR. Todd E. Rasmussen as Chief Surgical Officer

THOMSON REUTERS
·
May 12

Press Release: Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

Dow Jones
·
May 12

Humacyte Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 11

Humacyte risks Nasdaq delisting after shares trade below $1 bid price minimum

Reuters
·
May 09

Humacyte Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 08

Humacyte sets first-quarter results webcast and conference call

Reuters
·
May 08

Humacyte to Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026

THOMSON REUTERS
·
May 08

Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive

TIPRANKS
·
May 05

Humacyte (HUMA) Gets a Buy from Barclays

TIPRANKS
·
Apr 29

Humacyte Price Target Maintained With a $3.00/Share by BTIG

Dow Jones
·
Apr 28

Humacyte hosts virtual KOL event on ATEV for dialysis AV access

Reuters
·
Apr 27